Article contents
“Flakka”:an Emerging Trend Or a Mass Media Phenomenon? Presence ofalpha-pvpin Samples Submitted To a Drug Checking Facility
Published online by Cambridge University Press: 23 March 2020
Abstract
New psychoactive substances (NPS) are drugs that have recently become available, are not worldwide regulated, and often intend to mimic the effect of controlled drugs. α-Pyrrolidinopentiophenone ( alpha-PVP) is a potent stimulant cathinone that is thought to act inhibiting dopamine and noradrenaline reuptake. It has been associated with hallucinations, psychosis and death.
To explore the presence ofalpha-PVP from the samples handled to, and analyzed by energy control.
To determine whether it is a new trend in recreational settings.
all samples presented to energy control were analyzed.
Samples in which alpha-PVP was detected using Gas Chromatography-Mass Spectrometry were selected for study.
a Google trend analysis was also performed to asses the media impact of alpha-PVP.
From a total of 20,062 samples, 33 contained alpha-PVP (0.16%). The samples containing alpha-PVP were mostly sold as such (40%) despite a significant proportion being sold as MDM a (15%). Google trend analysis showed an abrupt increase of alpha-PVP searches in 2015 reaching 50% of the MDM a-ones.
Our results suggest presence ofalpha-PVP in the drug market may be increasing, especially as adulterant of other drugs. Severe side effects might be even more serious considering that a significant proportion of users may ignore which substance they are actually using. However, the total amount of alpha-PVP analyzed remains small, and does not support the alarming reports published in media.
The authors have not supplied their declaration of competing interest.
- Type
- EV624
- Information
- European Psychiatry , Volume 33 , Issue S1: Abstracts of the 24th European Congress of Psychiatry , March 2016 , pp. S442
- Copyright
- Copyright © European Psychiatric Association 2016
- 1
- Cited by
Comments
No Comments have been published for this article.